Additional equity from joint investor NB Renaissance will help the company at a 'turning point' in its history, says Ardian director Giacomo Forti.
Bluejay founding partner Putterman eyes tripling BWT's revenues over the next five years or so.
Russia’s full-scale invasion of Ukraine has made investments with links to the defence sector more palatable, said the head of private equity.
BioDue, a recent acquisition by Riverside, develops, manufactures and commercialises food supplements, medical devices and cosmetics.
Rezolv announced plans to build Europe’s largest solar photovoltaic plant in Arad County, Romania.
'Through its three business segments – manufacturing, labs and bio storage – Alcami serves as a one-stop shop for the pharma industry,' Vistria's Jon Maschmeyer said.
'The existing core business is paying the bills today and it's the bulk of our investment thesis right now, but we are also trying to think about the long run,' said Hawkins.
'This decarbonization movement is truly the biggest generational opportunity for the infrastructure asset class that will be in front of us over the next couple of decades,' George Yong said.
GTCR managing director Luke Marker discusses the Chicago PE firm's recent investment in the maker of coatings for medical devices.
After the pandemic-induced drop in air travel, traffic is surging at airports, putting the upgrading and modernization plans of JFK Terminal 6 in the spotlight.